Researcher
Peter Vandenberghe
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Department of Human Genetics (Department)
Member
From1 Apr 2009 → Today - Laboratory for Genetics of Malignant Disorders (Division)
Responsible
From1 Jan 2008 → Today
Projects
1 - 10 of 12 results
- Tracking Multiple Myeloma by low-pass sequencing of circulating cell free DNAFrom1 Mar 2019 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Circulating cell-free DNA as an alternative gateway to the genetic features of multiple myeloma and as a surrogate marker for disease burden in multiple myeloma.From1 Mar 2019 → TodayFunding: Nonprofit institution or equivalents
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2017 → TodayFunding: Foundations, funds and other with scientific goal
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2016 → 31 Dec 2019Funding: FWO research project
- The molecular pathogenesis of essential thrombocythemia: identification of novel signal transduction pathways and novel driver mutations.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
- Identification of recurrent genetic disorders in myeloproliferative neoplasms using an integrated genomics approach.From1 Jan 2011 → 30 Jun 2014Funding: Private funding of national origin - undefined
- Molecular genetics of mantle cell lymphoma.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- From individual cancer genes to integrated cancer pathways in childhood cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Deregulated signaling pathways in cancer: from genetic insights towards targeted therapy.From1 Oct 2010 → 30 Nov 2016Funding: BOF - Concerted Research Project from 1994
- Genomic and transcriptomic analyses of rare lymphomasFrom27 Sep 2010 → 5 Jul 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 211 results
- Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma(2020)Journal: BloodISSN: 0006-4971Issue: 19Volume: 135
Authors: Renate De Smedt, Julie Morscio, Lindy Reunes, Juliette Roels, Valentina Bardelli, Beatrice Lintermans, Wouter Van Loocke, Afonso Almeida, Laurence C Cheung, Rishi S Kotecha, et al.
Pages: 1685 - 1695Number of pages: 11 - Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma(2020)Journal: Genes, Chromosomes & CancerISSN: 1045-2257Issue: 8Volume: 59
Authors: Lieselot Buedts, Sanne Smits, Genevieve Ameye, Stefan Lehnert, Jia Ding, Michel Delforge, Joris Vermeesch, Nancy Boeckx, Thomas Tousseyn, Lucienne Michaux, et al.
Pages: 465 - 471Number of pages: 7 - The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.(2020)Journal: Nature CommunicationsIssue: 1Volume: 11
Authors: Ana Rio-Machin, Tom Vulliamy, Nele Hug, Amanda Walne, Kiran Tawana, Shirleny Cardoso, Alicia Ellison, Nikolas Pontikos, Jun Wang, Hemanth Tummala, et al.
Pages: 1044 - FER and FES tyrosine kinase fusions in follicular T-cell lymphoma(2020)Journal: BloodISSN: 0006-4971Issue: 8Volume: 135
Authors: Koen Debackere, Jo-Anne van der Krogt, Thomas Tousseyn, Julio Antonio Finalet Ferreiro, Katrien Van Roosbroeck, Lukas Marcelis, Carlos Graux, Daan Dierickx, Genevieve Ameye, Peter Vandenberghe, et al.
Pages: 584 - 588Number of pages: 6 - Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data(2020)Journal: PharmaceuticsISSN: 1999-4923Issue: 2Volume: 12
Authors: Gils Roex, Tom Feys, Yves Beguin, Tessa Kerre, Xavier Poire, Philippe Lewalle, Peter Vandenberghe, Dominique Bron, Sebastien Anguille
Number of pages: 15 - Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1(+) Leukemia (vol 19, pg 740, 2011)(2020)Journal: Cancer CellISSN: 1535-6108Issue: 1Volume: 37
Authors: Thomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, Sandra Cauwenberghs, Peter Fraisl, Christa Maes, Bart Jonckx, Kim De Keersmaecker, Maria Kleppe, Marc Tjwa, et al.
Pages: 135 - 136Number of pages: 2 - Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology(2020)Journal: OncoimmunologyISSN: 2162-4011Issue: 1Volume: 9
Authors: Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, et al.
Number of pages: 23 - Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study(2019)Journal: Lancet. HaematologyIssue: 11Volume: 6
Authors: Charlotte Maggen, Daan Dierickx, Pieternella Lugtenburg, Annouschka Laenen, Elyce Cardonick, Roman Smakov, Mar Bellido, Alvaro Cabrera-Garcia, Mina Mhallem Gziri, Michael J Halaska, et al.
Pages: E551 - E561Number of pages: 11 - Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes(2019)Journal: Genes, Chromosomes & CancerISSN: 1045-2257Issue: 10Volume: 58
Authors: Christina Ganster, Catharina Mueller-Thomas, Claudia Haferlach, Corinna Strupp, Kiyoyuki Ogata, Ulrich Germing, Barbara Hildebrandt, Mar Mallo, Michael Luebbert, Christel Mueller, et al.
Pages: 689 - 697Number of pages: 9 - Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.(2019)Journal: Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.KISSN: 0887-6924Issue: 8Volume: 33
Authors: H Pfeifer, G Cazzaniga, VHJ van der Velden, JM Cayuela, B Schäfer, O Spinelli, S Akiki, S Avigad, I Bendit, K Borg, et al.
Pages: 1910 - 1922